LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Efficacy and safety of interferon beta-1a for intramuscular injections biosimilar in patients with relapsing remitting multiple sclerosis

Photo by camstejim from unsplash

periependymal or diencephalic region, the areas considered as hallmarks of anti-AQP4 antibody positive-NMOSD brain lesions. Only one out of the four cases had prior infection, and the patients tended to… Click to show full abstract

periependymal or diencephalic region, the areas considered as hallmarks of anti-AQP4 antibody positive-NMOSD brain lesions. Only one out of the four cases had prior infection, and the patients tended to relapse without induction of maintenance therapy. Conclusion: Our findings indicate that anti-MOG antibody positive brain lesions are highly inflammatory in character, often presenting with meningitis. It is encephalitis with pathophysiology different from anti-AQP4 antibody mediated-astrocytic dysfunction found in seropositive NMO and yet clinically distinct from monophasic ADEM.

Keywords: injections biosimilar; beta intramuscular; efficacy safety; interferon beta; intramuscular injections; safety interferon

Journal Title: Journal of the Neurological Sciences
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.